Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C01CA03	NORADRENALINE NOREPINEPHRINE (tartrate) Aguettant	G	Norepinephrine tartrate - 2mg/ml	2mg/ml	Injectable solution	1,896,162 L.L
C01CA03	NORADRENALINE NOREPINEPHRINE (tartrate) Aguettant	G	Norepinephrine tartrate - 2mg/ml	2mg/ml	Injectable solution	1,896,162 L.L
C01CA03	NORADRENALINE HIKMA	G	Noradrenaline bitartrate - 4mg/4ml	4mg/4ml	Injectable solution	1,279,338 L.L
C01DA02	NITROGLICERINA BIOINDUSTRIA L.I.M.	G	Nitroglycerine - 50mg/50ml	50mg/50ml	Injectable concentrate for solution	1,057,604 L.L
C01DA02	NITROJECT INJECTION	G	Nitroglycerine - 50mg/10ml	50mg/10ml	Injectable solution	7,018,889 L.L
J01XE01	NITROFURANTOIN	G	Nitrofurantoin - 100mg	100mg	Tablet	972,942 L.L
C08CA06	NIMOTOP	B	Nimodipine - 30mg	30mg	Tablet, film coated	581,884 L.L
C08CA05	NIFELAT 60 LA	G	Nifedipine - 60mg	60mg	Tablet, prolonged release	1,290,089 L.L
C08CA05	NIFE-PAR	G	Nifedipine - 5mg/ml	5mg/ml	Solution	38,120,008 L.L
C08CA05	NIFELAT 30 LA	G	Nifedipine - 30mg	30mg	Tablet, prolonged release	1,007,882 L.L
C08CA05	NIFELAT R	G	Nifedipine - 20mg	20mg	Tablet, sustained release	388,370 L.L
C01DX16	NICORANDIL BIOGARAN	G	Nicorandil - 20mg	20mg	Tablet	822,432 L.L
C01DX16	NICORANDIL BIOGARAN	G	Nicorandil - 20mg	20mg	Tablet	822,432 L.L
C01DX16	NICORANDIL BIOGARAN	G	Nicorandil - 10mg	10mg	Tablet, scored	431,373 L.L
C01DX16	NICORANDIL BIOGARAN	G	Nicorandil - 10mg	10mg	Tablet, scored	431,373 L.L
C08CA04	NICARDIPINE ARROW	G	Nicardipine chlorhydrate - 10mg/10ml	10mg/10ml	Injectable solution	2,590,928 L.L
C08CA04	NICARDIPINE MEDIS	G	Nicardipine chlorhydrate - 10mg/10ml	10mg/10ml	Injectable solution	1,295,464 L.L
J05AG01	NEPINE	G	Nevirapine - 200mg	200mg	Tablet	5,921,678 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.30%	Drops solution	681,328 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.30%	Ointment	593,978 L.L
N07AA01	NEOSTIGMINE RENAUDIN	G	Neostigmine - 5mg/5ml	5mg/5ml	Injectable solution	2,460,576 L.L
N02BG06	NEO-PAN	G	Nefopam HCl - 20mg/2ml	20mg/2ml	Injectable solution	483,783 L.L
C07BB12	NEBILET PLUS	B	Nebivolol HCl - 5mg, Hydrochlorothiazide - 25mg		Tablet, film coated	716,268 L.L
C07BB12	NEBILET PLUS	B	Nebivolol HCl - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	716,268 L.L
C07BB12	NIVOL PLUS	G	Nebivolol HCl - 5mg, Hydrochlorothiazide - 12.5mg	5mg	Tablet	609,209 L.L
C07AB12	NEBILET	B	Nebivolol HCl - 5mg	5mg	Tablet, scored	694,767 L.L
C07AB12	NEBIVOLOL BIOGARAN	G	Nebivolol HCl - 5mg	5mg	Tablet, scored	529,474 L.L
C07AB12	NEVILOC	G	Nebivolol HCl - 5mg	5mg	Tablet	476,104 L.L
C07AB12	NIVOL	G	Nebivolol HCl - 5mg	5mg	Tablet	590,011 L.L
M01AE02	NAPROXENE SODIQUE ARROW	G	Naproxen (sodium) - 550mg	550mg	Tablet, film coated, scored	255,330 L.L